Regarding our case report, it is well known that VEGFR2 inhibitors lead to some adverse events such as proteinuria, hypertension, hand−foot syndrome, and kidney dysfunction whereas ICIs lead to other adverse events as autoimmune disorders, such as thyroiditis, colitis, skin disease, and different forms of nephritides. The gene discussed is KDR; the disease is colitis.